Bionano Genomics (NASDAQ:BNGO – Free Report) had its price target hoisted by BTIG Research to $10.00 in a report released on Thursday morning, Marketbeat.com reports. BTIG Research currently has a buy rating on the stock. Separately, LADENBURG THALM/SH SH cut their price objective on Bionano Genomics from $60.00 to $48.00 in a report on Wednesday, […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 48,120,000 shares, a drop of 19.5% from the June 15th total of 59,800,000 shares. Based on an average trading volume of 10,440,000 shares, the short-interest ratio is currently 4.6 […]
Bionano Genomics (NASDAQ:BNGO – Get Rating) and IsoPlexis (NASDAQ:ISO – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Earnings & Valuation This table compares Bionano Genomics and IsoPlexis’ […]
Akoya Biosciences (NASDAQ:AKYA – Get Rating) and Bionano Genomics (NASDAQ:BNGO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Volatility and Risk Akoya Biosciences has a beta of […]
Cim Investment Management Inc. lifted its stake in Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) by 100.0% in the fourth quarter, HoldingsChannel reports. The fund owned 59,784 shares of the company’s stock after purchasing an additional 29,892 shares during the quarter. Cim Investment Management Inc.’s holdings in Bionano Genomics were worth $253,000 at the end […]